You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lyso-thermosensitive liposomal doxorubicin

Showing 26 - 50 of 1,636
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hemophagocytic Lymphohistiocytosis Trial in Beijing (L-DEP and PD-1 antibody)

Not yet recruiting
  • Hemophagocytic Lymphohistiocytosis
  • L-DEP and PD-1 antibody
  • Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Apr 19, 2022

Advanced Malignant Tumors Trial in Shanghai (doxorubicin HCl liposome injection)

Recruiting
  • Advanced Malignant Tumors
  • doxorubicin hydrochloride liposome injection
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 28, 2022

Advanced Solid Tumors Trial in Switzerland (TLD-1, Caelyx)

Recruiting
  • Advanced Solid Tumors
  • Bellinzona, Switzerland
  • +3 more
Dec 24, 2021

Cardiotoxicity of Anthracyclines in Diffuse Large B-Cell

Active, not recruiting
  • Lymphoma
  • +2 more
  • R-CHOP with doxorubicin
  • Messina, ME, Italy
  • +17 more
Apr 22, 2022

Relapsed Sarcomas Trial in Cleveland (Disulfiram, Copper Gluconate, Liposomal Doxorubicin (Doxil))

Not yet recruiting
  • Relapsed Sarcomas
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Apr 18, 2022

Platinum-resistant Ovarian Cancer, Fallopian Tube Cancer, Epithelial Ovarian Cancer Trial (Pegylated Liposomal Doxorubicin +

Not yet recruiting
  • Platinum-resistant Ovarian Cancer
  • +6 more
  • Pegylated Liposomal Doxorubicin + SL-172154
  • Mirvetuximab + SL-172154
  • (no location specified)
Jul 29, 2022

Hemophagocytic Lymphohistiocytosis Trial in Beijing (DEP combine with PD-1 antibody)

Recruiting
  • Hemophagocytic Lymphohistiocytosis
  • DEP combine with PD-1 antibody
  • Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Feb 13, 2022

Recurrent Ovarian Cancer, Platinum-sensitive Ovarian Cancer Trial in Los Angeles (Simvastatin 40mg)

Recruiting
  • Recurrent Ovarian Cancer
  • Platinum-sensitive Ovarian Cancer
  • Simvastatin 40mg
  • Los Angeles, California
    Cedars Sinai Medical Center
Apr 21, 2022

Breast Cancer, Ovarian Cancer Trial in Guangzhou (Doxorubicin Hydrochloride Liposome Injection)

Recruiting
  • Breast Cancer
  • Ovarian Cancer
  • Doxorubicin Hydrochloride Liposome Injection
  • Guangzhou, Guangdong, China
    Sun Yat-Sun Memorial Hospital, Sun Yat-Sun University
Mar 8, 2022

Desmoid Tumor Trial in GuangZhou (Liposome doxorubicin, Saline Solution)

Recruiting
  • Desmoid Tumor
  • Liposome doxorubicin
  • Saline Solution
  • GuangZhou, Guangdong, China
    Sun Yat-sen University cancer center
Sep 29, 2022

Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer Trial in New

Suspended
  • Estrogen Receptor-negative Breast Cancer
  • +8 more
  • pegylated liposomal doxorubicin hydrochloride
  • +6 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Sep 20, 2021

Ovarian Cancer Trial in Worldwide (Carboplatin, Pegylated Lipoxomal Doxorubicin (PLD), Trabectedin)

Completed
  • Ovarian Cancer
  • Graz, AT, Austria
  • +131 more
Feb 8, 2022

Gaucher Disease Type 1, Gaucher Disease Type 3 Trial in Worldwide (venglustat (GZ402671), imiglucerase)

Active, not recruiting
  • Gaucher Disease Type 1
  • Gaucher Disease Type 3
  • New Haven, Connecticut
  • +6 more
Aug 9, 2022

Ovarian Cancer Trial in Indianapolis, Madison (Doxil (Pegylated Liposomal Doxorubicin), BIBF 1120)

Terminated
  • Ovarian Cancer
  • Doxil (Pegylated Liposomal Doxorubicin)
  • BIBF 1120
  • Indianapolis, Indiana
  • +1 more
Feb 14, 2022

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Carcinoma Trial in United States (Pazopanib, Doxil)

Terminated
Has Results
  • Ovarian Cancer
  • +2 more
  • Fort Myers, Florida
  • +3 more
Oct 4, 2021

Breast Cancer, HER2-positive Breast Cancer Trial in Xi'an (pegylated liposomal doxorubicin (PLD) plus cyclophosphamide followed

Recruiting
  • Breast Cancer
  • HER2-positive Breast Cancer
  • pegylated liposomal doxorubicin (PLD) plus cyclophosphamide followed by Nab-paclitaxel (Nab-P) ,continuously combined with dual HER2 blockage
  • Xi'an, Shaanxi, China
    Xijing Hospital ， Fourth Military Medical University
Apr 23, 2022

Relapsed Ovarian Cancer Trial in Roma (PLD and Trabectedin rechallenge)

Recruiting
  • Relapsed Ovarian Cancer
  • PLD and Trabectedin rechallenge
  • Roma, Italy
    Fondazione Policlinico Gemelli IRCCS
Aug 5, 2021

Metastatic Triple Negative Breast Cancer Trial in Dallas (PLD Chemotherapy, CDX-1140, CDX-301)

Recruiting
  • Metastatic Triple Negative Breast Cancer
  • PLD Chemotherapy
  • +2 more
  • Dallas, Texas
    UT Southwestern Medical Center
Jun 23, 2022

Cancer Trial (Empagliflozin 10 MG)

Not yet recruiting
  • Cancer
  • Empagliflozin 10 MG
  • (no location specified)
Oct 22, 2023

Rotator Cuff Tears, Postoperative Pain, Opioid Use Trial in Camden (Exparel Injectable Solution, Bupivacaine Injectable

Enrolling by invitation
  • Rotator Cuff Tears
  • +2 more
  • Exparel Injectable Solution
  • Bupivacaine Injectable Solution
  • Camden, New Jersey
    Cooper University Hospital
Nov 14, 2023

Advanced Soft-tissue Sarcoma Trial (LB-100 plus Doxorrubicin, Doxorubicin)

Not yet recruiting
  • Advanced Soft-tissue Sarcoma
  • (no location specified)
Apr 11, 2023

Breast Cancer Trial in Guandong (pegylated liposomal doxorubicin (PLD), cyclophosphamide (C), trastuzumab (H))

Recruiting
  • Breast Cancer
  • pegylated liposomal doxorubicin (PLD)
  • +5 more
  • Guandong, Guangdong, China
    Sunyat-sen Memorial Hospital
Feb 17, 2022

Cancer, Heart Failure, Arrhythmia Trial in Harbin (Control group:DH001 , Trial group: DH001 low-dose group, Trial group: DH001

Recruiting
  • Cancer
  • +4 more
  • Control group:DH001 placebo
  • +2 more
  • Harbin, Heilongjiang, China
    Harbin Institute of Hematology and Cancer
Oct 20, 2023

Rhabdomyosarcoma Trial in Palo Alto, Memphis, Fort Worth (Vincristine, Dactinomycin, Cyclophosphamide)

Not yet recruiting
  • Rhabdomyosarcoma
  • Palo Alto, California
  • +2 more
Aug 27, 2023

Liposomal Bupivacaine, Postoperative Recovery, Unilateral Knee Arthroplasty Trial in Nanjing (Nerve block with ropivacaine and

Recruiting
  • Liposomal Bupivacaine
  • +2 more
  • Nerve block with ropivacaine and intravenous analgesia
  • +2 more
  • Nanjing, Jiangsu, China
    Nanjing First Hospital
Nov 20, 2023